Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial US$ 29.60 Min. order: 1 piece ★★★★★ 4.3 (30 reviews) Sold : Login>>
Clinical trials of subcutaneous tirzepatide, retatrutide, and US$ 28.44 Min. order: 1 piece ★★★★★ 4.7 (216 reviews) Sold : Login>>
Novo Nordisk's CagriSema: promising but not perfect | Abdullah Melhim, MD, DABOM posted on the topic US$ 22.51 Min. order: 1 piece ★★★★★ 4.1 (92 reviews) Sold : Login>>
Retatrutide + Cagrilintide: The Weight Loss Stack Outperforming Ozempic [2026 Protocol] US$ 28.76 Min. order: 1 piece ★★★★★ 4.4 (91 reviews) Sold : Login>>
New trial data on CagriSema — 23% weight loss at 84 weeks in the RE-DEFINE 4 trial. CagriSema pairs semaglutide with cagrilintide, an amylin analogue. Amylin is a pancreatic hormone that slows US$ 26.99 Min. order: 1 piece ★★★★★ 4.0 (91 reviews) Sold : Login>>